logo
logo

Latest Financial Updates

Read latest financial news update from our blog

Talking to Candidates?
Talking to Candidates?

“You want me to read resumes and talk to candidates?” Roger protested. “I am not the hirin...

Admin | Finance | 2 months ago

read more
Former Netanyahu chief of staff Ari Harow convicted of fraud
Former Netanyahu chief of staff Ari Harow convicted of fraud

Former chief of staff of Prime Minister Benjamin Netanyahu's bureau Ari Harow was convicte...

Admin | Finance | 2 months ago

read more
How to Tell If a Prospective Workplace Is Toxic
How to Tell If a Prospective Workplace Is Toxic

New! HBR Learning Career Management Course Accelerate your career with Harvard ManageMe...

Admin | Finance | 2 months ago

read more
News Highlights : Top Company News of the Day - Wednesday at 9 AM ET -January 31, 2024 at 09:16 am EST
News Highlights : Top Company News of the Day - Wednesday at 9 AM ET -January 31, 2024 at 09:16 am EST

Boeing Says It Can't Set 2024 Financial Goals Amid 737 Max Woes The CEO said the company...

Admin | Finance | 2 months ago

read more
Nuvve Holding Corp. Announces Pricing of $9.6 Million Underwritten Public Offering
Nuvve Holding Corp. Announces Pricing of $9.6 Million Underwritten Public Offering

SAN DIEGO, Jan. 31, 2024 /PRNewswire/ -- Nuvve Holding Corp. ("Nuvve" or the "Company") (N...

Admin | Finance | 2 months ago

read more
Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of I
Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of I

Upcoming Lead Plaintiff Deadline is March 5, 2024 NEW YORK and CHICAGO, Jan. 31, 2024 /PR...

Admin | Finance | 2 months ago

read more
Teva to sell API activity
Teva to sell API activity

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) announced today its intention...

Admin | Finance | 2 months ago

read more
Biogen drops controversial Alzheimer’s drug
Biogen drops controversial Alzheimer’s drug

Biogen Inc. BIIB, -0.18% said Wednesday that it will halt the development and commercializ...

Admin | Finance | 2 months ago

read more

Join Our Newsletter

join our newsletter to receive update from us